Medinotec Inc. Stock Analysis MDNC

Medinotec, Inc. is a holding company, which engages in the manufacture and distribution of medical devices through its subsidiary. The company is headquartered in Johannesburg, Gauteng and currently employs 51 full-time employees. The company went IPO on 2023-03-21. The Company’s segments include Sales Outside the United States and Domestic Sales. The Sales Outside the United States segment includes both internally developed products and third-party products distributed under agreement. The Domestic Sales segment focuses on the proprietary Trachealator product within the United States. The firm manufactures and distributes medical devices that focus on tracheal non-occlusive airway dilatation technology. Its products include Trachealator, Cape Cross PTCA Catheter, Cape Cross Non-Compliant Catheter, Aortic Valve Dilatation Balloon Catheter, and Micro CTO Catheter. The products developed are sold through a network of distributors in many parts of the world and through a direct sales force in South Africa and the United States of America.